Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.
BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:
Early & Late Stage Pipeline Analysis
Biomarker/Companion Diagnostic Analysis
Deal & Alliance Analysis
Combination Therapy Analysis
Indication Selection & Expansion Analysis
Pipeline Analysis by Targeted Pathways
Analytical Tools transform your computer’s desktop into a high capacity workbench within your area of choice. Even before launching this desktop app you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf. It covers more than 72 companies plus partners who are today developing 291 fierce 15 in oncology drugs where of 201 are active in 600 developmental projects in cancer across 130 different targets. The Analytical Tool and its contents are yours to keep and data can be easily exported into Excel format for mixing with your own proprietary information.
Let our expertise work for you
While executing some of your daily tasks in our Analytical Tools you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.
Support and inspiration at your finger-tips
You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.
A tool to grow with and keep you informed
Unlike a static report which just represents a particular snapshot in time, all of BioSeeker’s Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features (valued at $2375), pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go completely online with our industry leading full service platform, 1stOncology.
Your key to accessing the 1stOncology Newsdesk
As a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.
Did you know?
The prestigious Fierce 15 biotech award has come to symbolize novelty and being at the forefront of biotechnology development amongst privately held businesses. The winners of this award are aiming at breakthroughs and big things, not at being 'me-too'.
This unique product, the 'Fierce 15 in Oncology Drug Pipeline Update' gathers the last six years (2010-2015) of Fierce 15 awards and identifies that no less than 54 of these biotech companies who are developing cancer drugs. This is a solid 60% of all companies given the award.
Fierce 15 companies are fast movers and to date no less than seventeen out of the 54 companies are public companies and four have been acquired, namely Amira Pharmaceuticals, Aragon Pharmaceuticals, Avila Therapeutics and Plexxikon.
FibroGen is the oldest among them, founded in 1993, otherwise all others are from the beginning of 2000 to present day. Among the very latest of the start-ups you will find Surface Oncology, Intellia Therapeutics, CRISPR Therapeutics, SQZ Biotech and Unum Therapeutics.
Available for the first time, Fierce 15 in Oncology lets you perform detailed pipeline analysis on their collective and very impressive pipeline of more than 290 drugs, spanning from Discovery to Marketed and in-house to co-development/in-licensing. Twenty eight drugs have one or more orphan drug designations and six drugs have received breakthrough therapy designation. Key technologies among this group of companies include CAR-T, TCRs, Immuno-oncology, Immune checkpoints, Gene editing etc.
BioSeeker’s Analytical Tools are a longstanding series of products powering decision making in oncology since 1999. Transform your computer’s desktop to a dedicated oncology workbench today! Request sample pages or order here to ensure you are not missing out on what you need to know.
Operating system: Windows (2000/XP/Vista/7/10) for Desktop App and Mac OSX access only via our online service.
Browser Application (Internet Explorer, FireFox, Chrome or Safari))
Internet access (to access related internet resources)
(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offer a Newsdesk product or similar news based service.
Electronic Access - Global Site License Fulfilled by Publisher
Electronic Access - Single User Fulfilled by Publisher